SenesTech Inc. (NASDAQ: SNES) Releases Q1 2024 Financial Results Reflecting ‘Outstanding Growth’
SenesTech reported record Q1 2024 revenue of $415,000, an increase of 78% compared to Q1 2023 and a 41% sequential increase from Q4 2023 The company attributes this growth to the introduction in January 2024 of Evolve(TM), its soft-bait product featuring breakthrough, next-generation technology that targets rat populations by using non-lethal methods to restrict fertility SenesTech is anticipating additional growth following the completion of an efficacy study providing data requested by certain state and international regulators, as this could open new markets that were previously inaccessible In May, the company also launched Evolve(TM) Mouse, a soft-bait product to control mouse…